Cosmos Pharmaceutical

Major retail groups · 3349

The Japan read

From the company's own filing for Full year to May 2026 · reported 2026-07-13 · the filing

StoresIt opened 105 stores (25 in Kyushu, 24 Kanto, 23 Chubu, 17 Kansai, 9 Shikoku, 7 Chugoku) and closed 6, ending May with 1,708, 59 with pharmacies. It says builders' labour shortages held up some construction, yet it opened 5 more than planned.
JapanGeneral food is 62.9% of sales and grew 11.7% to ¥691.7bn; medicines rose 2.3% to ¥143.9bn, cosmetics 5.1% to ¥97.9bn and household goods 4.4% to ¥157.6bn.
JapanExisting-store sales, which the company says improved from the second quarter, rose 5.5% in May 2026. Its latest monthly report shows −0.6% in June, +1.2% in July and +1.4% in August 2026, with 1,717 stores at end-August.

Other callouts in the filing

SegmentKyushu remains its biggest region at ¥471.5bn of sales from 673 stores, followed by Chugoku (¥151.8bn), Kansai (¥151.4bn), Kanto (¥112.1bn from 202 stores), Chubu (¥109.6bn) and Shikoku (¥102.9bn).
OutlookFor the year to May 2027 it forecasts net sales of ¥1,190.0bn (+8.2%), operating profit of ¥43.0bn (+1.5%) and net income of ¥30.7bn (−4.2%), with 120 openings including its first stores in Fukushima and Nagano.

floortok's reading of the filing, in our own words. Figures are the company's own; where a growth rate is our arithmetic, it says so.

Show figures in

Full year to May 2026

Reported 2026-07-13

Net sales¥1.10tn+8.7%

Operating profit¥42.4bn+4.8%

Net income¥32.0bn+3.4%

Cosmos Pharmaceutical runs discount drugstores where general food makes up 62.9% of sales, with 1,708 stores from Kyushu to Kanto. In the year to May 2026 net sales rose 8.7% to ¥1,099.6bn, operating profit 4.8% to ¥42.4bn and net income 3.4% to ¥32.0bn — its 35th straight year of sales growth.